Method for treating pain by peripheral administration of a neurotoxin

Details for Australian Patent Application No. 2001251546 (hide)

Owner Allergan, Inc

Inventors Jenkins, Stephen; Cui, Minglei; Aoki, Kei Roger

Agent Davies Collison Cave

Pub. Number AU-B-2001251546

PCT Pub. Number WO01/78760

Priority 09/550,371 14.04.00 US

Filing date 11 April 2001

Wipo publication date 30 October 2001

Acceptance publication date 1 July 2004

International Classifications

A61K 038/16 Medicinal preparations containing peptides - Peptides having more than 20 amino acids

A61K 038/48 Medicinal preparations containing peptides

A61P 029/02 Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

27 November 2003 Assignment before Grant

  Allergan Sales, Inc. The application has been assigned to Allergan, Inc.

1 July 2004 Application Accepted

  Published as AU-B-2001251546

14 October 2004 Opposition Lodged

  Societe de Conseils de Recherches et d'Applications Scientifiques has lodged an opposition against Allergan, Inc.

9 December 2004 Opposition Withdrawn

  The opposition by Societe de Conseils de Recherches et d'Applications Scientifiques against Allergan, Inc has been withdrawn.

9 December 2004 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001251547

2001251545